Annual Revenue
$58.50 B
-$41.83 B-41.70%
31 December 2023
Summary
Pfizer annual revenue is currently $58.50 billion, with the most recent change of -$41.83 billion (-41.70%) on 31 December 2023. During the last 3 years, it has risen by +$16.84 billion (+40.44%). PFE annual revenue is now -41.70% below its all-time high of $100.33 billion, reached on 31 December 2022.PFE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$17.70 B
+$4.42 B+33.26%
30 September 2024
Summary
Pfizer quarterly revenue is currently $17.70 billion, with the most recent change of +$4.42 billion (+33.26%) on 30 September 2024. Over the past year, it has increased by +$4.21 billion (+31.20%). PFE quarterly revenue is now -36.19% below its all-time high of $27.74 billion, reached on 01 June 2022.PFE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$59.37 B
+$4.21 B+7.63%
30 September 2024
Summary
Pfizer TTM revenue is currently $59.37 billion, with the most recent change of +$4.21 billion (+7.63%) on 30 September 2024. Over the past year, it has dropped by -$9.90 billion (-14.29%). PFE TTM revenue is now -41.37% below its all-time high of $101.28 billion, reached on 01 June 2022.PFE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.7% | +31.2% | -14.3% |
| 3 y3 years | +40.4% | -26.4% | -13.8% |
| 5 y5 years | +43.3% | +39.6% | +47.6% |
PFE Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.7% | +40.4% | -36.2% | +36.1% | -41.4% | +8.2% |
| 5 y | 5 years | -41.7% | +43.3% | -36.2% | +860.4% | -41.4% | +85.2% |
| alltime | all time | -41.7% | +1417.6% | -36.2% | +1824.4% | -41.4% | +6355.1% |
Pfizer Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $17.70 B(+33.3%) | $59.37 B(+7.6%) |
| June 2024 | - | $13.28 B(-10.7%) | $55.16 B(+0.5%) |
| Mar 2024 | - | $14.88 B(+10.1%) | $54.89 B(-6.2%) |
| Dec 2023 | $58.50 B(-41.7%) | $13.51 B(+0.1%) | $58.49 B(-15.6%) |
| Sept 2023 | - | $13.49 B(+3.7%) | $69.27 B(-11.7%) |
| June 2023 | - | $13.01 B(-29.6%) | $78.42 B(-15.8%) |
| Mar 2023 | - | $18.48 B(-23.9%) | $93.16 B(-7.2%) |
| Dec 2022 | $100.33 B(+23.4%) | $24.29 B(+7.3%) | $100.33 B(+0.5%) |
| Sept 2022 | - | $22.64 B(-18.4%) | $99.88 B(-1.4%) |
| June 2022 | - | $27.74 B(+8.1%) | $101.28 B(+9.6%) |
| Mar 2022 | - | $25.66 B(+7.6%) | $92.43 B(+13.7%) |
| Dec 2021 | $81.29 B(+95.2%) | $23.84 B(-0.8%) | $81.29 B(+18.0%) |
| Sept 2021 | - | $24.04 B(+27.2%) | $68.88 B(+25.0%) |
| June 2021 | - | $18.90 B(+30.2%) | $55.12 B(+19.6%) |
| Mar 2021 | - | $14.52 B(+27.0%) | $46.08 B(+10.6%) |
| Dec 2020 | $41.65 B(+1.8%) | $11.43 B(+11.2%) | $41.65 B(+29.9%) |
| Sept 2020 | - | $10.28 B(+4.2%) | $32.07 B(-7.0%) |
| June 2020 | - | $9.86 B(-2.2%) | $34.47 B(-9.0%) |
| Mar 2020 | - | $10.08 B(+447.1%) | $37.87 B(-7.4%) |
| Dec 2019 | $40.91 B(+0.2%) | $1.84 B(-85.5%) | $40.91 B(+1.7%) |
| Sept 2019 | - | $12.68 B(-4.4%) | $40.22 B(-1.5%) |
| June 2019 | - | $13.26 B(+1.1%) | $40.84 B(-0.5%) |
| Mar 2019 | - | $13.12 B(+1035.8%) | $41.04 B(+0.5%) |
| Dec 2018 | $40.83 B(-22.3%) | $1.16 B(-91.3%) | $40.83 B(-23.5%) |
| Sept 2018 | - | $13.30 B(-1.2%) | $53.37 B(+0.2%) |
| June 2018 | - | $13.47 B(+4.3%) | $53.24 B(+1.1%) |
| Mar 2018 | - | $12.91 B(-5.8%) | $52.67 B(+0.2%) |
| Dec 2017 | $52.55 B(-0.5%) | $13.70 B(+4.1%) | $52.55 B(+0.1%) |
| Sept 2017 | - | $13.17 B(+2.1%) | $52.47 B(+0.2%) |
| June 2017 | - | $12.90 B(+0.9%) | $52.35 B(-0.5%) |
| Mar 2017 | - | $12.78 B(-6.2%) | $52.60 B(-0.4%) |
| Dec 2016 | $52.82 B(+8.1%) | $13.63 B(+4.5%) | $52.83 B(-0.8%) |
| Sept 2016 | - | $13.04 B(-0.8%) | $53.24 B(+1.8%) |
| June 2016 | - | $13.15 B(+1.1%) | $52.29 B(+2.5%) |
| Mar 2016 | - | $13.01 B(-7.4%) | $50.99 B(+4.4%) |
| Dec 2015 | $48.85 B(-1.5%) | $14.05 B(+16.2%) | $48.85 B(+1.9%) |
| Sept 2015 | - | $12.09 B(+2.0%) | $47.92 B(-0.6%) |
| June 2015 | - | $11.85 B(+9.1%) | $48.20 B(-1.9%) |
| Mar 2015 | - | $10.86 B(-17.2%) | $49.12 B(-1.0%) |
| Dec 2014 | $49.60 B(-3.8%) | $13.12 B(+6.1%) | $49.60 B(-0.9%) |
| Sept 2014 | - | $12.36 B(-3.2%) | $50.05 B(-0.6%) |
| June 2014 | - | $12.77 B(+12.5%) | $50.33 B(-0.4%) |
| Mar 2014 | - | $11.35 B(-16.3%) | $50.53 B(-2.0%) |
| Dec 2013 | $51.58 B(-5.6%) | $13.56 B(+7.2%) | $51.58 B(-0.6%) |
| Sept 2013 | - | $12.64 B(-2.5%) | $51.92 B(-0.6%) |
| June 2013 | - | $12.97 B(+4.5%) | $52.23 B(-1.9%) |
| Mar 2013 | - | $12.41 B(-10.7%) | $53.22 B(-4.4%) |
| Dec 2012 | $54.66 B(-10.4%) | $13.89 B(+7.2%) | $55.70 B(+3.7%) |
| Sept 2012 | - | $12.95 B(-7.3%) | $53.72 B(-6.4%) |
| June 2012 | - | $13.97 B(-6.2%) | $57.38 B(-4.2%) |
| Mar 2012 | - | $14.88 B(+24.9%) | $59.90 B(-2.6%) |
| Dec 2011 | $61.03 B(-6.3%) | $11.92 B(-28.2%) | $61.51 B(-5.4%) |
| Sept 2011 | - | $16.61 B(+0.8%) | $65.06 B(+1.0%) |
| June 2011 | - | $16.48 B(-0.1%) | $64.44 B(-1.0%) |
| Mar 2011 | - | $16.50 B(+6.7%) | $65.09 B(-0.1%) |
| Dec 2010 | $65.17 B(+30.3%) | $15.46 B(-3.3%) | $65.17 B(-1.6%) |
| Sept 2010 | - | $15.99 B(-6.6%) | $66.24 B(+7.1%) |
| June 2010 | - | $17.13 B(+3.4%) | $61.87 B(+11.0%) |
| Mar 2010 | - | $16.58 B(+0.2%) | $55.72 B(+11.4%) |
| Dec 2009 | $50.01 B(+3.5%) | $16.54 B(+42.3%) | $50.01 B(+9.1%) |
| Sept 2009 | - | $11.62 B(+5.8%) | $45.82 B(-0.8%) |
| June 2009 | - | $10.98 B(+1.1%) | $46.17 B(-2.4%) |
| Mar 2009 | - | $10.87 B(-12.0%) | $47.31 B(-2.0%) |
| Dec 2008 | $48.30 B(-0.3%) | $12.35 B(+3.1%) | $48.30 B(-1.1%) |
| Sept 2008 | - | $11.97 B(-1.3%) | $48.82 B(-0.0%) |
| June 2008 | - | $12.13 B(+2.4%) | $48.84 B(+2.2%) |
| Mar 2008 | - | $11.85 B(-7.9%) | $47.79 B(-1.3%) |
| Dec 2007 | $48.42 B(+0.1%) | $12.87 B(+7.3%) | $48.42 B(+0.6%) |
| Sept 2007 | - | $11.99 B(+8.2%) | $48.15 B(-0.6%) |
| June 2007 | - | $11.08 B(-11.1%) | $48.44 B(-1.3%) |
| Mar 2007 | - | $12.47 B(-1.0%) | $49.10 B(+1.5%) |
| Dec 2006 | $48.37 B(+2.0%) | $12.60 B(+2.6%) | $48.37 B(+0.1%) |
| Sept 2006 | - | $12.28 B(+4.6%) | $48.31 B(+2.2%) |
| June 2006 | - | $11.74 B(-0.1%) | $47.30 B(+0.6%) |
| Mar 2006 | - | $11.75 B(-6.4%) | $47.01 B(-2.8%) |
| Dec 2005 | $47.41 B(-3.2%) | $12.55 B(+11.4%) | $48.35 B(+2.4%) |
| Sept 2005 | - | $11.26 B(-1.7%) | $47.20 B(-3.2%) |
| June 2005 | - | $11.45 B(-12.5%) | $48.77 B(-1.7%) |
| Mar 2005 | - | $13.09 B(+14.9%) | $49.59 B(+1.2%) |
| Dec 2004 | $48.99 B | $11.39 B(-11.2%) | $48.99 B(-5.0%) |
| Sept 2004 | - | $12.83 B(+4.5%) | $51.57 B(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $12.27 B(-1.7%) | $51.09 B(+4.9%) |
| Mar 2004 | - | $12.49 B(-10.7%) | $48.72 B(+8.9%) |
| Dec 2003 | $44.74 B(+38.5%) | $13.98 B(+13.2%) | $44.76 B(+11.8%) |
| Sept 2003 | - | $12.35 B(+24.7%) | $40.03 B(+12.2%) |
| June 2003 | - | $9.90 B(+16.1%) | $35.68 B(+7.9%) |
| Mar 2003 | - | $8.53 B(-7.9%) | $33.07 B(+2.4%) |
| Dec 2002 | $32.29 B(+11.3%) | $9.26 B(+15.7%) | $32.29 B(+11.2%) |
| Sept 2002 | - | $8.00 B(+9.6%) | $29.03 B(+0.6%) |
| June 2002 | - | $7.30 B(-5.8%) | $28.86 B(-1.3%) |
| Mar 2002 | - | $7.75 B(+29.2%) | $29.25 B(+0.3%) |
| Dec 2001 | $29.02 B(-1.1%) | $6.00 B(-23.4%) | $29.15 B(-6.6%) |
| Sept 2001 | - | $7.82 B(+1.8%) | $31.20 B(+2.2%) |
| June 2001 | - | $7.69 B(+0.5%) | $30.54 B(+2.3%) |
| Mar 2001 | - | $7.64 B(-5.0%) | $29.84 B(+1.6%) |
| Dec 2000 | $29.36 B(+7.2%) | $8.05 B(+12.4%) | $29.36 B(+1.8%) |
| Sept 2000 | - | $7.16 B(+2.4%) | $28.84 B(+1.4%) |
| June 2000 | - | $6.99 B(-2.4%) | $28.43 B(+1.7%) |
| Mar 2000 | - | $7.16 B(-5.0%) | $27.96 B(+13.1%) |
| Dec 1999 | $27.38 B(+17.8%) | $7.53 B(+11.7%) | $24.72 B(-19.6%) |
| Sept 1999 | - | $6.75 B(+3.5%) | $30.74 B(+12.5%) |
| June 1999 | - | $6.52 B(+65.9%) | $27.33 B(+13.3%) |
| Mar 1999 | - | $3.93 B(-71.0%) | $24.12 B(+3.8%) |
| Dec 1998 | $23.23 B(+110.1%) | $13.55 B(+307.0%) | $23.23 B(+82.2%) |
| Sept 1998 | - | $3.33 B(+0.5%) | $12.75 B(+4.8%) |
| June 1998 | - | $3.31 B(+9.1%) | $12.17 B(+3.4%) |
| Mar 1998 | - | $3.04 B(-1.2%) | $11.77 B(+0.3%) |
| Dec 1997 | $11.05 B(+12.1%) | $3.07 B(+11.8%) | $11.73 B(+13.0%) |
| Sept 1997 | - | $2.75 B(-5.7%) | $10.38 B(-0.5%) |
| June 1997 | - | $2.91 B(-3.0%) | $10.44 B(+2.5%) |
| Mar 1997 | - | $3.00 B(+74.7%) | $10.18 B(+3.2%) |
| Dec 1996 | $9.86 B(-1.6%) | $1.72 B(-38.7%) | $9.86 B(-9.4%) |
| Sept 1996 | - | $2.80 B(+5.3%) | $10.89 B(+2.5%) |
| June 1996 | - | $2.66 B(-0.8%) | $10.63 B(+1.7%) |
| Mar 1996 | - | $2.68 B(-2.3%) | $10.45 B(+2.7%) |
| Dec 1995 | $10.02 B(+21.0%) | $2.74 B(+8.1%) | $10.17 B(+4.6%) |
| Sept 1995 | - | $2.54 B(+2.3%) | $9.72 B(+5.0%) |
| June 1995 | - | $2.48 B(+3.3%) | $9.26 B(+6.4%) |
| Mar 1995 | - | $2.40 B(+4.5%) | $8.70 B(+5.1%) |
| Dec 1994 | $8.28 B(+10.7%) | $2.30 B(+10.9%) | $8.28 B(+3.9%) |
| Sept 1994 | - | $2.07 B(+7.9%) | $7.97 B(+2.6%) |
| June 1994 | - | $1.92 B(-3.0%) | $7.77 B(+2.3%) |
| Mar 1994 | - | $1.98 B(-0.3%) | $7.59 B(+1.5%) |
| Dec 1993 | $7.48 B(+3.4%) | $1.99 B(+6.2%) | $7.48 B(+0.6%) |
| Sept 1993 | - | $1.87 B(+7.1%) | $7.44 B(+0.6%) |
| June 1993 | - | $1.75 B(-6.4%) | $7.39 B(+0.7%) |
| Mar 1993 | - | $1.87 B(-4.1%) | $7.34 B(+1.5%) |
| Dec 1992 | $7.23 B(+4.0%) | $1.95 B(+6.5%) | $7.23 B(+1.4%) |
| Sept 1992 | - | $1.83 B(+7.9%) | $7.13 B(+0.8%) |
| June 1992 | - | $1.69 B(-3.8%) | $7.08 B(+0.9%) |
| Mar 1992 | - | $1.76 B(-4.8%) | $7.02 B(+0.9%) |
| Dec 1991 | $6.95 B(+8.5%) | $1.85 B(+4.4%) | $6.95 B(+0.9%) |
| Sept 1991 | - | $1.77 B(+8.7%) | $6.89 B(+1.9%) |
| June 1991 | - | $1.63 B(-3.8%) | $6.76 B(+2.0%) |
| Mar 1991 | - | $1.70 B(-5.0%) | $6.62 B(+3.3%) |
| Dec 1990 | $6.41 B(+13.0%) | $1.79 B(+8.7%) | $6.41 B(+4.8%) |
| Sept 1990 | - | $1.64 B(+9.8%) | $6.11 B(+3.5%) |
| June 1990 | - | $1.50 B(+0.9%) | $5.91 B(+3.4%) |
| Mar 1990 | - | $1.48 B(-0.8%) | $5.72 B(+0.8%) |
| Dec 1989 | $5.67 B(+5.3%) | $1.49 B(+3.9%) | $5.67 B(+2.3%) |
| Sept 1989 | - | $1.44 B(+10.4%) | $5.55 B(+1.0%) |
| June 1989 | - | $1.30 B(-9.3%) | $5.49 B(-0.6%) |
| Mar 1989 | - | $1.44 B(+5.0%) | $5.52 B(+2.6%) |
| Dec 1988 | $5.39 B(+9.5%) | $1.37 B(-1.1%) | $5.39 B(+1.8%) |
| Sept 1988 | - | $1.38 B(+3.5%) | $5.29 B(+1.6%) |
| June 1988 | - | $1.34 B(+3.0%) | $5.21 B(+2.1%) |
| Mar 1988 | - | $1.30 B(+1.8%) | $5.10 B(+3.6%) |
| Dec 1987 | $4.92 B(+9.9%) | $1.28 B(-1.7%) | $4.92 B(+2.3%) |
| Sept 1987 | - | $1.30 B(+5.8%) | $4.81 B(+2.9%) |
| June 1987 | - | $1.23 B(+9.6%) | $4.67 B(+2.4%) |
| Mar 1987 | - | $1.12 B(-3.7%) | $4.56 B(+2.0%) |
| Dec 1986 | $4.48 B(+11.2%) | $1.16 B(-0.0%) | $4.48 B(+2.4%) |
| Sept 1986 | - | $1.16 B(+4.0%) | $4.37 B(+3.6%) |
| June 1986 | - | $1.12 B(+8.3%) | $4.22 B(+2.8%) |
| Mar 1986 | - | $1.03 B(-2.4%) | $4.10 B(+2.2%) |
| Dec 1985 | $4.02 B(+4.4%) | $1.06 B(+4.5%) | $4.02 B(+2.3%) |
| Sept 1985 | - | $1.01 B(+1.1%) | $3.93 B(+0.8%) |
| June 1985 | - | $1.00 B(+5.9%) | $3.90 B(+0.4%) |
| Mar 1985 | - | $945.70 M(-2.1%) | $3.88 B(+0.7%) |
| Dec 1984 | $3.85 B | $966.30 M(-1.7%) | $3.85 B(+33.5%) |
| Sept 1984 | - | $982.70 M(-0.3%) | $2.89 B(+51.6%) |
| June 1984 | - | $985.70 M(+7.2%) | $1.91 B(+107.2%) |
| Mar 1984 | - | $919.80 M | $919.80 M |
FAQ
- What is Pfizer annual revenue?
- What is the all time high annual revenue for Pfizer?
- What is Pfizer annual revenue year-on-year change?
- What is Pfizer quarterly revenue?
- What is the all time high quarterly revenue for Pfizer?
- What is Pfizer quarterly revenue year-on-year change?
- What is Pfizer TTM revenue?
- What is the all time high TTM revenue for Pfizer?
- What is Pfizer TTM revenue year-on-year change?
What is Pfizer annual revenue?
The current annual revenue of PFE is $58.50 B
What is the all time high annual revenue for Pfizer?
Pfizer all-time high annual revenue is $100.33 B
What is Pfizer annual revenue year-on-year change?
Over the past year, PFE annual revenue has changed by -$41.83 B (-41.70%)
What is Pfizer quarterly revenue?
The current quarterly revenue of PFE is $17.70 B
What is the all time high quarterly revenue for Pfizer?
Pfizer all-time high quarterly revenue is $27.74 B
What is Pfizer quarterly revenue year-on-year change?
Over the past year, PFE quarterly revenue has changed by +$4.21 B (+31.20%)
What is Pfizer TTM revenue?
The current TTM revenue of PFE is $59.37 B
What is the all time high TTM revenue for Pfizer?
Pfizer all-time high TTM revenue is $101.28 B
What is Pfizer TTM revenue year-on-year change?
Over the past year, PFE TTM revenue has changed by -$9.90 B (-14.29%)